Anzeige
Mehr »
Donnerstag, 27.11.2025 - Börsentäglich über 12.000 News
Kupfer-Superzyklus voraus: Dieses Top-Projekt in Nevada wird jetzt zum echten Investmentcase
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiTruist names Lo Li to lead consumer banking technology division
MiA2Z Smart Technology stock rises after Benchmark reiterates Buy rating
MiBenchmark reiterates Buy rating on Analog Devices stock, maintains $285 target
MiRepublic Power receives Nasdaq non-compliance notice over delayed filing
MiMoleculin Biotech announces 1-for-25 reverse stock split
MiAllegiant to offer up to 40% off flights during 48-hour cyber sale
MiE.W. Scripps adopts shareholder rights plan after acquisition offer
MiXOMA Royalty to acquire Mural Oncology for $2.035 per share
MiAspire Biopharma adds pioneering drug delivery expert to scientific team
MiMainStreet Bancshares announces CFO retirement, succession plan
MiWingstop reaches 3,000 restaurant milestone in global expansion
MiNukkleus-backed SPAC prices $150 million initial public offering
MiVisionWave appoints European lead to advance Solar Drone deployment
MiFibroBiologics repays convertible notes, eliminating dilution risk
MiDDC expands bitcoin holdings by 100 BTC amid market pullback
MiBrunswick increases tender offer cap for senior notes to $100 million
MiAlto Ingredients director resigns to lead The Lifetime Group
MiDeFi Development Corp. executives purchase additional shares in open market
MiVistagen presents data on PH80 for menopausal hot flashes treatment
MiEmory University Hospital adopts Microbot's LIBERTY robotic system
MiBrunswick increases tender offer cap for 2052 notes to $100 million
MiAxis Bank issues Rs 5,000 crore in non-convertible debentures
MiCleanSpark stock price target lowered to $27 at H.C. Wainwright on AI pivot
MiH.C. Wainwright reaffirms Buy rating on Plus Therapeutics stock at $2.00
MiH.C. Wainwright initiates coverage on reAlpha Tech stock with Buy rating